history of glp-1 drugs glucagon-like peptide-1 receptor agonists Complete Guide to GLP-1 Medications
Description
GLP-1/GLP-1R signaling in regulation of adipocyte differentiation and lipogenesis

E., Hayes, M
Renal Extraction and Acute Effects of Glucagon-Like Peptide-1 on Central and Renal Hemodynamics in Healthy Men

Potential safety issues Pancreatic and thyroid risk Beyond gastrointestinal adverse events, which are widely accepted as a class effect of GLP-1 RAs, 65 , 66 several other safety concerns have been raised over the past decade

Dual GLP-1/glucagon receptor agonists, including mazdutide, integrate appetite suppression with increased energy expenditure and fat oxidation, while triple GLP-1/GIP/glucagon agonists, such as retatrutide, further augment these mechanisms through multi-pathway receptor engagement
Heart Failure Current evidence overall does not support the routine use of GLP-1 RAs to improve cardiac function or reduce HF hospitalizations
